Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Cash on Hand 2017–2025
Aclaris Therapeutics, Inc. annual cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Aclaris Therapeutics, Inc. cash on hand as of December 31, 2025: 20.0M, a 18.76% decrease year-over-year.
- Aclaris Therapeutics, Inc. cash on hand for 2025 were 20.0M, a 18.76% decrease from 2024.
- Aclaris Therapeutics, Inc. cash on hand for 2024 were 24.6M, a 38.39% decrease from 2023.
- Aclaris Therapeutics, Inc. cash on hand for 2023 were 39.9M, a 11.92% decrease from 2022.
- Aclaris Therapeutics, Inc. cash on hand for 2022 were 45.3M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aclaris Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $20 |
| 2024 | $25 |
| 2023 | $40 |
| 2022 | $45 |
| 2021 | $27 |
| 2020 | $22 |
| 2019 | $34 |
| 2018 | $168 |
| 2017 | $20 |
Aclaris Therapeutics, Inc. Cash on Hand — FAQ
Aclaris Therapeutics, Inc. (ACRS) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's cash on hand history?
The chart and table above show Aclaris Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.